Abstract
Abstract
Aims
To identify socioeconomic, behavioral and clinical factors that are associated with prediabetes according to different prediabetes definition criteria.
Methods
Analyses use pooled data of the population-based Cooperative Health Research in the Region of Augsburg (KORA) studies (n = 5312 observations aged ≥ 38 years without diabetes). Prediabetes was defined through either impaired fasting glucose (IFG), impaired glucose tolerance (IGT) or elevated HbA1c according to thresholds of the American Diabetes Association. Explanatory variables were regressed on prediabetes using generalized estimating equations.
Results
Mean age was 58.4 years; 50% had prediabetes (33% had IFG, 16% IGT, and 26% elevated HbA1c, 10% fulfilled all three criteria). Age, obesity, hypertension, low education, unemployment, statutory health insurance, urban residence and physical inactivity were associated with prediabetes. Male sex was a stronger risk factor for IFG (OR = 2.5; 95%–CI: 2.2–2.9) than for IGT or elevated HbA1c, and being unemployed was a stronger risk factor for IGT (OR = 3.2 95%–CI: 2.6–4.0) than for IFG or elevated HbA1c.
Conclusions
The overlap of people with IFG, IGT and elevated HbA1c is small, and some factors are associated with only one criterion. Knowledge on sociodemographic and socioeconomic risk factors can be used to effectively target interventions to people at high risk for type 2 diabetes.
Funder
Bundeszentrale für gesundheitliche Aufklärung
Publisher
Springer Science and Business Media LLC
Reference40 articles.
1. American Diabetes Association (2018). Complications. https://www.diabetes.org/living-with-diabetes/complications/. Accessed 7 May 2020.
2. World Health Organization (2018). Global health estimates 2016: deaths by cause, age, sex, by country and by region, 2000–2016. https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death. Accessed 7 May 2020
3. Hex N, Bartlett C, Wright D, Taylor M, Varley D (2012) Estimating the current and future costs of Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs. Diabet Med 29:855–862
4. Seuring T, Archangelidi O, Suhrcke M (2015) The economic costs of type 2 diabetes: a global systematic review. Pharmacoecon Open 33:811–831
5. World Health Organization (2016) Global report on diabetes. World Health Organization, Geneva
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献